CMC Invest sees AUD 6.08 target for Regis Healthcare stock
Published on 10/15/2026 at 22:08 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSInvestor metrics and timing
- On October 12, 2026, CMC Invest put the average Regis Healthcare target at AUD 6.08.
- Fiscal year 2026 revenue reached AUD 1.35 billion, up 16 percent year over year.
- Regis Healthcare stock costs EUR 2.70 at Lang & Schwarz on October 15, 2026 at 10:05 p.m. CEST, 0.46 percent above the Xetra close of October 15, 2026.
- Regis Healthcare's price-to-earnings ratio was 23.70 on October 15, 2026.
CMC Invest sees an average AUD 6.08 target for Regis Healthcare, putting the target 39.13 percent above the ASX price of AUD 4.37 on October 15, 2026. According to The Motley Fool Australia on October 12, 2026, six analyst ratings produced that average target. Regis Healthcare stock was trading at EUR 2.70 at Lang & Schwarz on October 15, 2026 at 10:05 p.m. CEST, 0.46 percent above the Xetra close of October 15, 2026 at EUR 2.69.
Revenue growth sets the baseline
Regis Healthcare reported fiscal year 2026 revenue of AUD 1.35 billion, up 16 percent from fiscal year 2025, while net income reached AUD 55.70 million, up 14 percent. The reported net profit margin was 4.10 percent, down from 4.20 percent in fiscal year 2025, according to Simply Wall St.
Stock stays below the yearly high
The ASX quote stood at AUD 4.37 at 4:10 p.m. AEDT on October 15, 2026, with a session high of AUD 4.44, a low of AUD 4.33 and volume of 998,400 shares. The 52-week range ran from AUD 3.85 to AUD 8.20, leaving the stock 46.71 percent below its high and 13.51 percent above its low.
The latest fiscal year also leaves valuation as a key market reference. Regis Healthcare had a market capitalization of AUD 1.3 billion and a price-to-earnings ratio of 23.70 on October 15, 2026. The next annual general meeting is scheduled for November 17, 2026, according to Kapitales Research.
Target distance remains material
The AUD 6.08 average target sits well above the latest ASX quote, while the euro quotation remains below its October 15 Xetra comparison. That gap leaves the analyst view and the margin trend as the two clearest figures for assessing the stock's current positioning.
Regis Healthcare stock was trading at EUR 2.70 at Lang & Schwarz on October 15, 2026 at 10:05 p.m. CEST, 0.46 percent above the Xetra close of October 15, 2026 at EUR 2.69. The further course of trading is shown by the continuously updated real-time quote of Regis Healthcare stock.
Regis Healthcare market profile
- Company: Regis Healthcare Limited
- ISIN: AU000000REG6
- Ticker: REG
- Primary exchange: ASX
- Price Lang & Schwarz (as of October 15, 2026, 10:05 p.m. CEST): EUR 2.70
- Change versus Xetra close: plus 0.46 percent
- Xetra close (October 15, 2026): EUR 2.69
- Market capitalization: AUD 1.3 billion (as of October 15, 2026)
- Sector / Industry: Healthcare / Medical - Care Facilities
Market context: Market report S&P/ASX 200.
